Alzheimer Disease
- Name
- Alzheimer Disease
- Accession Number
- DBCAT003011
- Description
Not Available
- Drugs
Drug Drug Description Latrepirdine Latrepirdine has been investigated for the treatment of Alzheimer's Disease and Huntington's Disease. Lecanemab An amyloid beta-targeting antibody used to treat Alzheimer’s Disease in patients with mild cognitive impairment or mild dementia with a known amyloid beta pathology. - Drugs & Drug Targets
Drug Target Type Lecanemab Amyloid beta A4 protein target